The first in vitro fertilization: the birth of Louise Brown and a new scientific era

On July 25, 1978, Louise Brown was born in the United Kingdom. Her arrival into the world was watched with unusual attention for a birth: doctors, journalists, scientists and families closely followed an event that marked a before and after in medicine.

At that time, Louise was the first person born through in vitro fertilization. But her story is not limited to a date or a scientific fact. The reality was far more complex.

This event opened a conversation that continues to this day: how medicine responds to infertility, what role technology plays in human reproduction, and why major healthcare advances not only transform treatments, but also the way a society understands its own limits.

From suspicion to consensus

It is hard to imagine from today’s perspective, but at the time in vitro fertilization was met with distrust. There were religious and ethical objections, alarmist headlines and a public debate over whether science was crossing a line it should not.

Institutional recognition took decades to arrive. Robert Edwards, the scientist who led the research, did not receive the Nobel Prize in Medicine until 2010, thirty-two years after that birth. His colleague Patrick Steptoe, however, had already passed away and could not receive it, as the Nobel Prize is not awarded posthumously.

That journey between initial suspicion and clinical consensus is a pattern that has often repeated itself throughout the history of medicine. And understanding it matters, because it is exactly the kind of judgment needed today to rigorously assess advances such as gene editing or fertility preservation.

The social side of the advance

Before in vitro fertilization, many people struggling to conceive were met with few medical answers and a great deal of social silence. In many cases, infertility was experienced as a lonely reality, surrounded by frustration, guilt or misunderstanding.

Lesley and John Brown, Louise’s parents, had been trying to conceive for nine years when they agreed to take part in the research. They did so with no guarantee that the pregnancy would progress or that the baby would be born healthy. Their decision, made under conditions of maximum uncertainty, illustrates the human role that also lies behind major scientific advances.

The birth of their daughter did not eliminate the emotional complexity that comes with infertility, but it did make it possible to approach it from a different place: that of research, diagnosis and medical treatment. That shift was both medical and cultural: it helped move infertility from the realm of taboo to that of health.

What made in vitro fertilization possible

In vitro fertilization is an assisted reproduction technique in which the egg is fertilized outside the body. The resulting embryo is then transferred to the uterus in an attempt to allow its development to continue.

Put that way, it may seem like a simple procedure. However, behind that explanation lie years of research, trials and technical limitations, as well as extremely delicate clinical decisions. The challenge was not only to achieve fertilization in a laboratory, but to do so in a way that was viable, safe and applicable to medical practice. And that was made possible thanks to collaboration between gynecology, embryology, biology, nursing and laboratory work.

The story of an advance built by a team

The first in vitro fertilization is often associated with Robert Edwards and Patrick Steptoe, two fundamental names in this story. Edwards was the scientist who drove the development of the technique, while Steptoe contributed his clinical expertise in gynecology and laparoscopy.

But the story of this advance is not truly complete without Jean Purdy, a nurse and embryologist whose role was essential in the laboratory work and in monitoring the embryos. For years, her contribution received less public recognition than that of her colleagues, although today she is considered a key figure in the development of in vitro fertilization.

Her story adds an important reading: medical science does not advance only thanks to great names, but to teams capable of bringing together knowledge, technical precision and perseverance. In health, an innovative idea needs professionals who know how to turn it into clinical practice.

From breakthrough to routine

Since 1978, assisted reproduction has evolved significantly. Techniques have been refined, treatments have become safer and knowledge about fertility has advanced until it has become a medical field in its own right. More than twelve million people have been born worldwide thanks to in vitro fertilization, a figure equivalent to the population of a medium-sized country. What was an exception in 1978 is now part of the global demographic landscape.

But it is important to avoid an overly optimistic reading: it is not an automatic solution and it does not always guarantee a pregnancy. Each treatment involves a different physical, emotional and clinical process. There are expectations, uncertainty, medical decisions and, sometimes, difficult outcomes to accept. All of this requires rigorous information, professional support and, above all, an ethical perspective on each case.

What that birth represents today

More than four decades later, in vitro fertilization continues to generate debate: up to what age a treatment makes sense, who has access and who does not, how egg preservation is regulated, and what role emotional support plays when the results are not as expected.

None of these questions can be answered by technology alone. They require clinical judgment, an ethical framework and professionals capable of moving between the laboratory, the consultation room and each patient’s real life. And that capacity can only be built through education.

At Universidad Mundae, we understand healthcare education through that same logic. Health-related programs are designed to train professionals capable of combining scientific knowledge, clinical judgment and care for people, the three ingredients that make it possible for an advance to become real change.

New challenges, same demand

Each generation of healthcare professionals faces its own version of that 1978 debate: a new technique, an ethical question with no clear answer, a society that hesitates. Gene editing, artificial intelligence applied to diagnosis or fertility preservation are the current names of that same conversation.